You'll see fewer patients getting prescriptions for the antidepressant Serzone

You'll see fewer patients getting prescriptions for the antidepressant Serzone...due to concerns about liver toxicity.

Bristol-Myers Squibb just pulled it off the market in Europe.

Health Canada and the FDA issued warnings just last year.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote